Investing.com - Oncology Institute (NASDAQ: TOI) reported first quarter EPS of $-0.21, $0.10 worse than the analyst estimate of $-0.11. Revenue for the quarter came in at $86M versus the consensus estimate of $82.04M.
Oncology Institute's stock price closed at $1.84. It is down -9.80% in the last 3 months and up 179.00% in the last 12 months.
Oncology Institute saw 1 positive EPS revisions and 0 negative EPS revisions in the last 90 days. See Oncology Institute's stock price’s past reactions to earnings here.
According to InvestingPro, Oncology Institute's Financial Health score is "good performance".
Check out Oncology Institute's recent earnings performance, and Oncology Institute's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar